AMH, Inhibin A, FSH, and Ovarian Cancer Risk in the JANUS Serum Bank

Nathaniel Rothman

Studies in the Janus Cohort

Ovary

Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Ovary

Hematology and hematologic malignancies Pathology

Thomas A Sellers

Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)

Ovary

Pathology

Julia Salzman

Discovering genomic rearrangements under selection in serious ovarian cancer

Ovary

Scott H Kaufmann

Mayo Clinic SPORE in Ovarian Cancer

Ovary

Pathology

Vincent DeGennaro

National Cancer Treatment Program

Stomach Ovary Non-Hodgkin lymphoma Nasopharynx Leukaemia Larynx Kaposi sarcoma Hodgkin lymphoma Colorectum Breast

Lesley M Butler

Urinary Metalloproteinases and Ovarian Cancer Risk in a Prospective Cohort

Ovary

Pathology

The Role of microRNA, mir-30d, in the Initiation and Progression of Cancer

Ovary Breast

Dipanjan Chowdhury

Molecular mechanism and relevance of microRNAs in DSB repair pathway choice

Ovary Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Radiation Oncology